Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) Short Interest Up 28.0% in March

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) was the target of a large increase in short interest in the month of March. As of March 31st, there was short interest totaling 463,069 shares, an increase of 28.0% from the March 15th total of 361,705 shares. Approximately 5.0% of the shares of the company are sold short. Based on an average daily volume of 151,489 shares, the days-to-cover ratio is presently 3.1 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Zepp Health in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $64.37.

Zepp Health Stock Up 17.0%

ZEPP stock opened at $16.41 on Friday. Zepp Health has a twelve month low of $2.22 and a twelve month high of $61.85. The company has a quick ratio of 0.77, a current ratio of 1.02 and a debt-to-equity ratio of 0.28. The stock has a market cap of $237.93 million, a P/E ratio of -6.54 and a beta of 1.76. The business’s 50-day moving average price is $17.42 and its 200-day moving average price is $26.93.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ZEPP. Ariose Capital Management Ltd purchased a new position in shares of Zepp Health during the 3rd quarter valued at about $1,269,000. Trivest Advisors Ltd purchased a new position in shares of Zepp Health during the 3rd quarter valued at about $13,503,000. Keystone Investors PTE Ltd. purchased a new position in shares of Zepp Health during the 3rd quarter valued at about $4,811,000. UBS Group AG lifted its position in shares of Zepp Health by 16,412.0% during the 3rd quarter. UBS Group AG now owns 181,302 shares of the company’s stock valued at $8,300,000 after buying an additional 180,204 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Zepp Health during the 3rd quarter valued at about $1,895,000. 52.61% of the stock is owned by hedge funds and other institutional investors.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.